<?xml version="1.0" encoding="UTF-8"?>
<p>ImunoAce Flu showed 89.2% specificity (95%CI: 84.1–93.1), which is relatively low (
 <xref rid="pone.0231217.t001" ref-type="table">Table 1</xref>). When the study population was limited to patients who were tested within 48 hours after the onset of illness, the specificity was 90.4% (95%CI: 85.1–94.3) (
 <xref rid="pone.0231217.t002" ref-type="table">Table 2</xref>). In contrast, the specificity was &gt;99.9% (95%CI: 99.4–100) in the meta-analysis report [
 <xref rid="pone.0231217.ref009" ref-type="bibr">9</xref>]. The manuals for the other RIDT kits used in Japan report their sensitivity (88%–100%) and specificity (94%–100%) [
 <xref rid="pone.0231217.ref019" ref-type="bibr">19</xref>]. The low specificity in the present study may be attributable to the characteristics of the monoclonal antibody used in the ImunoAce Flu test kit.
</p>
